Smirta Innovations
Smirta Innovations is a privately held US digital health company that sells OncoSmart, an AI-powered EHR-overlay platform that optimizes scheduling, nurse assignment, and operational analytics for community oncology clinics and multi-site oncology networks.
- Company typePrivate
- Founded2019
- HeadquartersNorth Brunswick, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Smirta Innovations does
Smirta Innovations Inc. is a privately held, US-based digital health company that sells the OncoSmart platform — an AI-powered, EHR-agnostic overlay purpose-built for community oncology clinics. Founded in 2019 and headquartered in Holmdel, New Jersey, the company operates with a small team (1–10 employees) and bootstrapped-style finances, with no disclosed institutional funding rounds. The platform addresses the operational complexity of cancer care delivery, where patients typically require multiple same-day services (labs, MA, physician, infusion, injections), nursing skills vary, and demand concentrates into punishing mid-day peaks.
OncoSmart consists of three integrated modules: iOptimize, which uses adaptive, rules-based algorithms to recommend appointment times that flatten the daily utilization curve; iAssign, which automates nurse and treatment-room assignment based on patient acuity, nursing skill level, and real-time staff availability; and iNtellisite, which provides real-time and historical business intelligence dashboards, KPI tracking, and event-triggered alerts for front-office, nursing, and leadership teams. The platform is co-developed with Tennessee Oncology and integrates with major oncology and general EHRs (OncoEMR, Varian Aria, Epic, Cerner, Meditech, VieCure), positioning it as a complementary layer rather than a replacement for existing infrastructure.
Smirta monetizes OncoSmart through enterprise SaaS subscriptions with accompanying implementation and customer success services, sold exclusively via a direct, consultative enterprise sales motion to community oncology practices and multi-site oncology networks in the United States. Named customers include Piedmont Cancer Institute, New Mexico Cancer Center, Oklahoma Cancer Specialists and Research Institute, and the OneOncology network (300+ sites of care), with the company citing outcomes of a 5X decrease in wait times, a 29% increase in capacity, an 86% decrease in extended hours, and a 6–7X first-year ROI. Marketing is content-driven (white papers, case studies, webinars, press) targeting C-suite and operational leadership at oncology practices.
Smirta Innovations firmographics
Firmographics- Name
- Smirta Innovations
- Legal name
- Smirta Innovations Inc.
- Website
- https://smirta.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Smirta Innovations is a privately held US digital health company that sells OncoSmart, an AI-powered EHR-overlay platform that optimizes scheduling, nurse assignment, and operational analytics for community oncology clinics and multi-site oncology networks.
- Ownership category
- akta.pro rank
Smirta Innovations industry classification
Industry- Product category
- Oncology Practice Management Software
- NAICS
- Software Publishers (513210), Computer Systems Design and Related Services (5415)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD)
Keywords
Where Smirta Innovations is headquartered
LocationHeadquarters
- HQ city
- North Brunswick
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Smirta Innovations business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- SaaS Platform Subscription (OncoSmart): OncoSmart is sold as a SaaS platform to community oncology practices. Based on the enterprise sales motion, contact forms capturing clinic size (number of chairs, clinics), and customer success manager hiring, the revenue model is consistent with subscription-based SaaS, likely priced per clinic, per module, or as an enterprise platform agreement with annual recurring fees.
- Implementation and Professional Services: Customer success manager role, implementation coordination, training, and sales presentations are referenced as part of the engagement model, suggesting professional services revenue alongside platform subscriptions.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels10 records
Smirta Innovations product offering
Product offeringCore offering
Smirta Innovations is an information technology company that sells the OncoSmart Platform, an AI-powered digital transformation overlay for community oncology clinics. The platform optimizes infusion suite scheduling, automates nurse-to-patient assignments, and provides predictive business intelligence to improve clinic throughput, patient access, and operational efficiency.
Product overview
Smirta Innovations offers the OncoSmart Platform, a unified AI-powered digital transformation platform specifically designed for oncology centers. The platform consists of three integrated modules: iOptimize (scheduling optimization), iAssign (nurse and treatment room assignment automation), and iNtellisite (business intelligence and reporting). These modules work together to optimize scheduling workflows, automate resource allocation, and provide real-time operational visibility across community cancer clinics.
Differentiator
Problem solved
Functional benefit
Brands
- OncoSmart: AI-powered digital transformation platform that optimizes and simplifies the complexities of community cancer clinic scheduling and nurse assignment operations. Includes three specialized modules: iOptimize, iAssign, and iNtellisite.
Products and services
- OncoSmart Platform AI-powered digital transformation platform for community oncology practices that serves as an intelligent layer over existing EHR systems to optimize scheduling, staffing, and clinical operations.
- iOptimize Scheduling and resource optimization module of the OncoSmart Platform that uses AI to maximize infusion chair and suite utilization for oncology clinics.
- iAssign Nurse-to-patient assignment automation module of the OncoSmart Platform that intelligently allocates nursing staff based on treatment complexity and patient acuity.
- iNtellisite Business intelligence and predictive analytics module of the OncoSmart Platform providing operational dashboards, anomaly detection, and actionable insights for oncology practice leadership.
Quantifiable outcome
- 5X decrease in patient wait times
- +6 more outcomes
Companies that use Smirta Innovations
Customer profileNamed customers5 records
Segments2 records
Ideal customer profiles1 record
Smirta Innovations technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration7 records
AI capability6 records
Feature4 records
Smirta Innovations partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- OneOncologycoreOneOncology selected Smirta as a preferred vendor to deploy the OncoSmart platform across the OneOncology network of physician practices. OneOncology is a national partnership of independent community oncologists with over 300 sites of care, 960 providers, and approximately 528,000 patients nationwide. The partnership aims to enhance efficiency, capacity, and patient experience across community oncology clinics through AI-powered scheduling optimization and nurse assignment tools.
Scale indicators10 records
Recent moves5 records
Expansion highlights5 records
Smirta Innovations competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Smirta Innovations social profiles
Digital presenceSmirta Innovations financial estimates
Financial estimateRevenue estimate
Valuation estimate
Smirta Innovations leadership team
Management profileNumber of profiles
Profiles1 record
Smirta Innovations funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Smirta Innovations M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Smirta Innovations
What does Smirta Innovations do?
Smirta Innovations is an information technology company that sells the OncoSmart Platform, an AI-powered digital transformation overlay for community oncology clinics. The platform optimizes infusion suite scheduling, automates nurse-to-patient assignments, and provides predictive business intelligence to improve clinic throughput, patient access, and operational efficiency.
Is Smirta Innovations a public or private company?
Smirta Innovations is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Smirta Innovations founded?
Smirta Innovations was founded in 2019. It employs 11 to 50 people.
Where is Smirta Innovations based?
Smirta Innovations is headquartered in North Brunswick, United States, in the North America region.
How does Smirta Innovations make money?
Two revenue lines are on record. SaaS Platform Subscription (OncoSmart) is the primary driver. The others are implementation and Professional Services.
Does Smirta Innovations have an API?
No public API is recorded for Smirta Innovations.
What industry is Smirta Innovations in?
Smirta Innovations's product category is Oncology Practice Management Software. Its primary akta.pro industry code is HLALAFAD, Oncology Remote Symptom Monitoring & Care Navigation. Its NAICS code is 513210 and its SIC code is 7372.